Intellego Technologies publicerade den 25 augusti år 2022 bolagets delårsrapport för andra kvartalet...
ChromoGenics publicerade den 25 augusti 2022 sin delårsrapport för årets andra kvartal.
AcouSort publicerade den 24:e augusti 2022 sin delårsrapport för Q2-22.
Redeye leaves its comments on Idogen following the report for the second quarter of 2022.
Redeye comments briefly on the rights issue outcome of SEK 215m raised and adjusts our fair value ra...
One of the important hurdles for the ramp-up of Zwipe Pay has been certification by Visa and Masterc...
Redeye comments on BioInvent's second quarter report.
Affär med Corem slutförd Omsättningen i Q2'22 uppgick till 4,4 mdkr.
Redeye comments on Scandion’s Q2 2022 report, coming shortly before the company plans to communicate...
Redeye is encouraged to see Episurf delivering on its activities for inclusion in UK NICE guidelines...
Zoomability publicerade den 24 augusti 2022 bolagets delårsrapport för årets andra kvartal.
Surprisingly strong order intake at E&P and MTH DK Order book increase to DKK 12bn bodes well for fu...
Redeye states that the Q2 report was weaker than expected but that mobile accessories delivered good...
Redeye comments on C Security's Q2 report, which was below our expectations in terms of revenues but...
Redeye will likely only make smaller estimate changes after Gapwaves’ Q2 2022 report, wherein it pos...
Q2: Limited deviations on sales and adj. EBITDA Small negative cons adj.
Redeye leaves a comment on the Q2 report published by Alzinova earlier today.
We adapt a NAV-focused approach Företagsparken the largest growth driver NAVPS growth 10% every year...
Redeye updates its estimates following Safeture’s Q2 report.
Redeye comments on Beyond Frames Q2’22 report, which came in below our expectations.
